These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 17724495)

  • 61. A rotavirus vaccine for infants: the Asian experience.
    Phua KB; Emmanuel SC; Goh P; Quak SH; Lee BW; Han HH; Ward RL; Bernstein DI; De Vos B; Bock HL
    Ann Acad Med Singap; 2006 Jan; 35(1):38-44. PubMed ID: 16470273
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 oral suspension (liquid formulation) in Finnish infants.
    Vesikari T; Karvonen A; Bouckenooghe A; Suryakiran PV; Smolenov I; Han HH
    Vaccine; 2011 Mar; 29(11):2079-84. PubMed ID: 21238572
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.
    Clark HF; Offit PA; Plotkin SA; Heaton PM
    Pediatr Infect Dis J; 2006 Jul; 25(7):577-83. PubMed ID: 16804425
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rotavirus vaccines in developed countries.
    Buttery JP; Kirkwood C
    Curr Opin Infect Dis; 2007 Jun; 20(3):253-8. PubMed ID: 17471034
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines.
    Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE
    Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S377-82. PubMed ID: 26590437
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Rotavirus vaccine].
    Ushijima H; Ishida S
    Nihon Rinsho; 2008 Oct; 66(10):1977-83. PubMed ID: 18939500
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh.
    Feller AJ; Zaman K; Lewis KD; Hossain I; Yunus M; Sack DA
    Vaccine; 2012 Apr; 30 Suppl 1():A101-5. PubMed ID: 22520118
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and safety of pentavalent human-bovine reassortant rotavirus vaccine when administered with greater than 10 weeks between doses.
    Goveia MG; Suprun L; Itzler RF; McFetridge R; Dallas MJ; Kuter BJ
    Pediatr Infect Dis J; 2010 Mar; 29(3):263-5. PubMed ID: 19949360
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunogenicity of a three dose and five dose oral human rotavirus vaccine (RIX4414) schedule in south Indian infants.
    Kompithra RZ; Paul A; Manoharan D; Babji S; Sarkar R; Mathew LG; Kang G
    Vaccine; 2014 Aug; 32 Suppl 1():A129-33. PubMed ID: 25091666
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rotavirus: realising the potential of a promising vaccine.
    Nelson EA; Glass RI
    Lancet; 2010 Aug; 376(9741):568-70. PubMed ID: 20692032
    [No Abstract]   [Full Text] [Related]  

  • 71. [New rotavirus vaccines: a reality at last].
    O'Ryan M
    Rev Chilena Infectol; 2005 Dec; 22(4):345-54. PubMed ID: 16341356
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of safety and immunogenicity of a live attenuated tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus vaccine (BRV-TV) in healthy Indian adults and infants.
    Dhingra MS; Kundu R; Gupta M; Kanungo S; Ganguly N; Singh MP; Bhattacharya MK; Ghosh R; Kumar R; Sur D; Chadha SM; Saluja T
    Vaccine; 2014 Aug; 32 Suppl 1():A117-23. PubMed ID: 25091664
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Rotavirus Vaccine. Statement of the Consultive Committee of Immunizations on behalf of The Chilean Infectious Diseases Society. March 2006].
    Muñoz M A; Abarca V K; Luchsinger F V; Valenzuela B MT; Jiménez de la J J;
    Rev Chilena Infectol; 2006 Jun; 23(2):124-7. PubMed ID: 16721445
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The future of rotavirus vaccines.
    Offit PA
    Semin Pediatr Infect Dis; 2002 Jul; 13(3):190-5. PubMed ID: 12199615
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intussusception following rotavirus vaccination: an updated review of the available evidence.
    Rha B; Tate JE; Weintraub E; Haber P; Yen C; Patel M; Cortese MM; DeStefano F; Parashar UD
    Expert Rev Vaccines; 2014 Nov; 13(11):1339-48. PubMed ID: 25066368
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Skin Vaccination against Rotavirus Using Microneedles: Proof of Concept in Gnotobiotic Piglets.
    Wang Y; Vlasova A; Velasquez DE; Saif LJ; Kandasamy S; Kochba E; Levin Y; Jiang B
    PLoS One; 2016; 11(11):e0166038. PubMed ID: 27824918
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rotavirus vaccine and intussusception. Where do we go from here?
    Dennehy PH; Bresee JS
    Infect Dis Clin North Am; 2001 Mar; 15(1):189-207, x-xi. PubMed ID: 11301815
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis.
    Burnett E; Parashar UD; Tate JE
    Lancet Glob Health; 2020 Sep; 8(9):e1195-e1202. PubMed ID: 32827481
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rotavirus vaccines.
    Kang G
    Indian J Med Microbiol; 2006 Oct; 24(4):252-7. PubMed ID: 17185842
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rotarix: development of a live attenuated monovalent human rotavirus vaccine.
    Bernstein DI; Ward RL
    Pediatr Ann; 2006 Jan; 35(1):38-43. PubMed ID: 16466074
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.